Document:

QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 4.7  

  
 

    FORM OF AMENDED AND RESTATED
  SHAREHOLDERS AGREEMENT    
    

        THIS AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (this "Agreement"), dated as
of            , 2004, is by and
among Merisant Worldwide, Inc., a Delaware corporation formerly known as Tabletop Holdings, Inc. (together with any corporate successor thereto, whether by merger, consolidation, or
otherwise, the "Company"), Tabletop Holdings, LLC, a Delaware limited liability company (the
"LLC"), the persons named in Exhibit A as Initial Investors (the "Initial
Investors") and the persons named in Exhibit A as Additional Investors (the "Additional
Investors," and, together with the Initial Investors, the "Investors"). The Investors, together with the Company and the LLC,
are hereinafter referred to as the "Parties." In this Agreement, "Shareholders" shall refer to the LLC
and the Investors. 

        WHEREAS,
the Company, the LLC and the Initial Investors are parties to that certain Shareholders Agreement dated as of March 17, 2000 (the "Existing
Shareholders Agreement"); 

        WHEREAS,
the Company is presently contemplating an initial public offering of its income deposit securities ("IDSs"), each representing
one share of the Company's Class A Common Stock, par value $0.01 per share (together with any securities issued or distributed in respect thereof, or in substitution therefor, the
"Class A Common Stock") and $            principal amount of the Company's    % Senior Subordinated Notes due 2019
(the
"Senior Subordinated Notes") as well as a separate issuance of $            principal amount of the Senior Subordinated Notes (not in the form
of
IDSs) (the "Separate Senior Subordinated Notes," the issuance of the IDSs and the Separate Senior Subordinated Notes herein referred to as the
"Offering"); 

        WHEREAS,
in connection with the Offering and immediately preceding the consummation thereof, each issued and outstanding share of common stock, par value $0.01 per share (the
"Existing Common Stock"), of the Company will be converted into            shares of Class B Common Stock, par value $0.01 per share
(together with any securities issued or distributed in respect thereof, or in substitution therefor (other than pursuant to Article VI hereof), the "Class B
Common Stock," and, together with the Class A Common Stock, the "Common Stock"), of the Company (the
"Conversion") pursuant to the Amended and Restated Certificate of Incorporation of the Company; 

        WHEREAS,
immediately after the Conversion, each of the LLC and the Initial Investors will be the owner of the number of shares of Class B Common Stock set forth opposite its name
on Exhibit A hereof; 

        WHEREAS,
upon the completion of the Offering, the Company shall, subject to the terms and conditions set forth in this Agreement, repurchase from the LLC and the Initial Investors
Class B Common Stock as set forth in Section 7.2 hereof; 

        WHEREAS,
promptly after the consummation of the Offering, each of the Additional Investors and certain of the Initial Investors, as a result of their receipt of shares of Class B
Common Stock pursuant to the Company's Stock Appreciation Rights Plan ("SAR Plan") (and assuming no exercise of the Over-Allotment Option),
will be the owner of the additional number of shares of Class B Common Stock set forth opposite its name on Exhibit A hereof; 

        WHEREAS,
pursuant to an underwriting agreement entered into among the Company and the underwriters of the Offering (collectively, the
"Underwriters"), the Company has granted the Underwriters an option to purchase additional IDSs (the "Over-Allotment
Option"), the proceeds of which, if exercised, will be used by the Company to repurchase a portion of the remaining shares of Class B Common Stock held by the
Shareholders as set forth in Section 7.3 hereof; 

        WHEREAS,
pursuant to Section 1 of the Existing Shareholders Agreement, the Shareholders have agreed to vote for and consent to any actions required with respect to the Offering
and raise no 

 

objections
against the Offering and to take all reasonable actions in connection with the consummation of the Offering as requested by the Board of Directors of the Company (the
"Board"); 

        WHEREAS,
entrance into this Agreement is a condition to each of the Additional Investors' and certain of the Initial Investors' receipt of Class B Common Stock pursuant to the SAR
Plan; 

        WHEREAS,
it is necessary, in connection with the consummation of the Offering, for the Shareholders to make certain representations and agreements as set forth herein; and 

        WHEREAS,
the Parties now desire to amend and restate the Existing Shareholders Agreement in its entirety, effective upon consummation of the Offering. 

        NOW,
THEREFORE, in consideration of the mutual promises made herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties,
intending to be legally bound, agree that this Agreement shall, in accordance with Section 7.1 hereof, amend and supersede in its entirety the Existing Shareholders Agreement, and agree as
follows: 

Article I

 Representations, Warranties and Covenants of the Company  

        1.1    Representations, Warranties and Covenants of the
Company.    The Company represents and warrants to, and covenants and agrees with, each of the Shareholders as follows: 

        (a)   The
Company is a corporation validly existing and in good standing under the laws of the State of Delaware. 

        (b)   The
Company has full corporate power and corporate authority to make, execute, deliver and perform this Agreement and to carry out all of the transactions provided for
herein. 

        (c)   The
Company has taken such corporate action as is necessary or appropriate to enable it to perform its obligations hereunder, and this Agreement constitutes the legal,
valid and binding obligation of the Company, enforceable against the Company in accordance with the terms hereof. 

        (d)   The
Company will not acquire, directly or indirectly, any interest in , or derivative position determined by referenc to the value of, any Senior Subordinated Notes or
Separate Senior Subordinated Notes, except through a repurchase or redemption of 100% of the Senior Subordinated Notes and Separate Senior Subordinated Notes outstanding, whether issued in connection
with the Offering, or thereafter; provided, however, that the Company or any of its subsidiaries may
acquire IDSs. 

        (e)   The
Company is not party to, and is not aware of, any plan, agreement or arrangement pursuant to which any person who is purchasing Separate Senior Subordinated Notes in
the Offering would or could acquire any IDSs or any capital stock of the Company or transfer any of the Separate Senior Subordinated Notes to any holder of IDSs or capital stock of the Company. The
Company has no
actual knowledge that the representations contained in the Registration Statement on Form S-1, as amended, filed with the Securities and Exchange Commission in connection with the
Offering (the "Form S-1") set forth under the heading "Notice to Purchasers of Separate Senior Subordinated Notes and Acknowledgement
of Purchaser Intent" will be untrue as of the time such representations are to be made by any person who is purchasing Separate Senior Subordinated Notes in the Offering. 

        (f)    In
connection with the annual audit of the Company's financial statements by its independent auditors, the Company agrees to make reasonable efforts to cooperate with
the Company's independent auditors for the purpose of confirming the accuracy of the representations and compliance by the Company and each Shareholder, as applicable, with the covenants contained in
Sections 1.1(d) and (e) and Sections 2.1(c), (d) and (e) hereof. 

2

 
Article II

 Representations, Warranties and Covenants of Each Shareholder  

        2.1    Representations, Warranties and Covenants of Each
Shareholder.    Each of the Shareholders severally represents and warrants to, and covenants and agrees with, the Company as follows: 

        (a)   Such
Shareholder has full legal right, capacity, power and authority (including the due authorization by all necessary corporate or partnership action in the case of
corporate or partnership Shareholders) to enter into this Agreement and to perform such Shareholder's obligations hereunder without the need for the consent of any other person or entity; and this
Agreement has been duly authorized, executed and delivered and constitutes the legal, valid and binding obligation of such Shareholder, enforceable against such Shareholder in accordance with the
terms hereof. 

        (b)   Such
Shareholder has received a copy of the Form S-1, and has been given the opportunity to obtain information regarding the business and affairs of
the Company to such Shareholder's satisfaction. 

        (c)   Such
Shareholder (and any of such Shareholder's affiliates, as defined below) will not acquire, directly or indirectly (other than as a result of the exchange rights set
forth in Article VI hereof), any Separate Senior Subordinated Notes or IDSs in the Offering or at any time after the Offering, in each case until such time as such Shareholder (and any of such
Shareholder's affiliates) no longer owns an equity interest in the Company or any rights to acquire an equity interest in the Company. Such Shareholder (and any of such Shareholder's affiliates)
currently has no plan, intent or arrangement of any kind to complete the direct or indirect acquisition of any Separate Senior Subordinated Notes or IDSs other than in accordance with
Article VI hereof. As used in this Section 2.1, an "affiliate" of a Shareholder shall mean (i) any person bearing a relationship to the Shareholder described in
Section 267(b) of the Internal Revenue Code of 1986, as amended, or (ii) any person owned or controlled by the Shareholder or by the same interests as the Shareholder within the meaning
of Section 482 of the Internal Revenue Code of 1986, as amended. 

        (d)   Such
Shareholder (and any of such Shareholder's affiliates) will not, directly or indirectly, enter into a constructive ownership transaction within the meaning of
Section 1260(d) of the Internal Revenue Code of 1986, as amended, with respect to the Separate Senior Subordinated Notes (assuming that the Separate Senior Subordinated Notes are financial
assets for the purposes of Section 1260(d)) until such time as such Shareholder (and any of such Shareholder's affiliates) no longer owns an equity interest in the Company or any rights to
acquire an equity interest in the Company. 

        (e)   Such
Shareholder has read the section of the Form S-1 entitled "Notice to Purchasers of Separate Senior Subordinated Notes and Acknowledgement of
Purchaser Intent" and has no actual knowledge that any representation contained therein will be untrue at the time such representation is made by any person who is purchasing Separate Senior
Subordinated Notes in the Offering. Such Shareholder is not aware of any plan or arrangement whereby any purchaser of Separate Senior Subordinated Notes in the Offering would or could acquire any IDSs
or any capital stock of the Company or transfer the Separate Senior Subordinated Notes to any holder of IDSs or capital stock of the Company. 

        (f)    In
connection with the annual audit of the Company's financial statements by its independent auditors, such Shareholder agrees to make commercially reasonable efforts to
cooperate with the Company's independent auditors for the purpose of confirming the accuracy of the representations and the compliance by each Shareholder, as applicable, with the representations and
covenants contained in Sections 2.1(c), (d) and (e) hereof. 

3

 

        (g)   Effective
upon the consummation of the Offering, such Shareholder hereby waives any preemptive rights or registration rights, or the failure to receive advance notice
under any such rights, that such Shareholder may have had under the Existing Shareholders Agreement, and any such preemptive rights or registration rights under the Existing Shareholders Agreement
shall no longer be of any force or effect. 

        (h)   The
number of shares of Existing Common Stock held of record and beneficially by such Shareholder (prior to giving effect to the Conversion) is set forth opposite such
Shareholder's name on Exhibit A. Such Shareholder has good, valid and marketable title to the Existing Common Stock held by such Shareholder free
and clear of any liens, charges, claims, pledges, security interests, conditional sale agreements and other encumbrances whatsoever (other than the Existing Shareholders Agreement). 

        (i)    Such
Shareholder has not Transferred (as hereinafter defined) all or any part of the Existing Common Stock held by such Shareholder. 

        2.2    Reliance.    Each Shareholder
acknowledges that the Company and each of the other Shareholders is entering into this Agreement in reliance upon such Shareholder's representations and warranties and other covenants and agreements
contained herein, and that counsel to the Company and counsel to the underwriters and the Company's lenders will rely upon such Shareholder's representations and warranties and other covenants and
agreements contained herein for the purpose of issuing certain opinions to the Company, to the underwriters and to the lenders in connection with the Offering and related transactions. 

Article III

 Transfer Restrictions  

        3.1    Provisions Regarding Transfers of Shares of Class B Common
Stock.    The following provisions shall apply with respect to the Transfer (as hereinafter defined) of any shares of Class B Common
Stock owned by any Shareholder: 

        (a)   Each
Shareholder is prohibited from Transferring any of his or its Class B Common Stock except as contemplated by Article VI hereof or to Permitted
Transferees (as hereinafter defined); provided, however, that no Transfer shall be effected except in
compliance with the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), (and applicable state securities laws)
or pursuant to an available exemption therefrom. 

        (b)   No
Transfer shall, in any event, be made by any Shareholder unless in connection with such Transfer, the applicable transferee has complied with the terms and provisions
of this Agreement. No Shareholder or transferee may effect any Transfer of shares of Class B Common Stock, whether to a Permitted Transferee or otherwise (other than in compliance with
Article VI hereof), unless the transferee executes an agreement pursuant to which such transferee agrees to be bound by the terms and provisions of this Agreement applicable to the transferor
(except as otherwise specifically provided herein). Any purported Transfer in violation of this covenant shall be null and void and of no force and effect and the purported transferee shall have no
rights or privileges in or with respect to the Company. As used herein, "Transfer" means the making of any sale, exchange, assignment, hypothecation,
gift, security interest, pledge or other encumbrance, or any contract therefor, any voting trust or other agreement or arrangement with respect to the transfer of voting rights (including any proxy or
similar arrangement (whether or not revocable)) or any other beneficial interest in any of the shares of Class B Common Stock, the creation of any other claim thereto or any other transfer or
disposition whatsoever, whether voluntary or involuntary, affecting the right, title, interest or possession in or to such shares of Class B Common Stock. 

4

 

        Prior
to any proposed Transfer of any shares of Class B Common Stock (other than in accordance with Article VI hereof), the holder thereof shall give written notice to the
Company describing the manner and circumstances of the proposed Transfer accompanied, if requested by the Company, by a written opinion of legal counsel reasonably satisfactory to the Company,
addressed to the Company and the transfer agent, if other than the Company, and reasonably satisfactory in form and substance to each addressee, to the effect that the proposed Transfer of the shares
of Class B Common Stock may be effected without registration under the Securities Act and applicable state securities laws. Each certificate evidencing the shares transferred shall bear the
legend set forth in Section 3.2, except that such certificate shall not bear such legend if the opinion of counsel referred to above is to the
further effect that such legend is not required in order to establish compliance with any provision of the Securities Act or applicable state securities laws. 

        (c)(i) If
any Shareholder other than the LLC desires to Transfer shares of Class B Common Stock (other than in accordance with Article VI hereof) (such
Shareholder being herein referred to as the "Transferor Shareholder"), then such Transfer must be to a person who shall have made a  bona fide offer to
purchase such shares and the Transferor Shareholder shall promptly furnish to all other Shareholders (the
"Shareholder Offerees") and the Company a notification (the "Notice of Transfer") of such desire to
Transfer such shares and of the bona fide offered price for such shares proposed to be Transferred, the method of payment of such offered price, the
identity of the prospective purchaser or purchasers (the "Proposed Purchaser") and all other pertinent terms and conditions of such  bona fide offer.

         (ii)  For
a period of 15 days commencing on the date of its receipt of the Notice of Transfer, the Shareholder Offerees shall have the right to purchase all or any
portion of the shares of Class B Common Stock proposed to be Transferred upon the same terms and conditions and at the bona fide offer price as
described in the Notice of Transfer. The specific portion of such shares which each Shareholder Offeree shall be so entitled to purchase shall be determined on a pro rata basis in proportion to the
respective shares of each Shareholder Offeree desiring to purchase the offered shares
available for purchase. Any Shareholder Offeree desiring so to purchase such shares shall give notification of such desire to the Transferor Shareholder and the Company and all other Shareholder
Offerees confirming such desire and the proposed terms of purchase. In the event that any Shareholder Offeree does not purchase its full pro rata share of any such shares proposed to be Transferred,
such unpurchased shares shall be offered by the Transferor Shareholder to the Shareholder Offerees subscribing to purchase shares on a pro rata basis on similar terms of purchase. In the event that
the Shareholder Offerees do not purchase, in accordance with the provisions of this clause (ii), all of the shares proposed to be Transferred as described in the Notice of Transfer, the Company
shall have the exclusive right, by a vote of the disinterested directors, to agree to purchase all or any portion of such shares proposed to be Transferred that remain after the application of this  Section 3.1(c)(ii)
 upon the same terms and conditions as described in the Notice of Transfer. If the Company desires to so purchase such shares
it shall give notification of such desire to the Transferor Shareholder and all other Shareholders confirming such desire and the proposed terms of purchase. No such shares shall be made available for
purchase by any non-Shareholder pursuant to the remaining provisions of this Section 3.1 unless and until all Shareholder Offerees
and the Company shall have had an opportunity to purchase all such shares in accordance with the provisions of this clause (ii). 

        (iii)  The
closing of any purchase by the Company or any Shareholder Offerees of any offered shares of Class B Common Stock as provided in this  Section 3.1(c) shall take place on such date as designated
by the Company or such Shareholder Offeree occurring within 30 days after
receipt by the Transferor Shareholder of the last notification to be provided to the 

5

 

Transferor
Shareholder in accordance with the terms hereof from the Company or such Shareholder Offeree of the exercise of the Company's or such Shareholder Offeree's right to purchase hereunder. At
such closing, the Transferor Shareholder shall deliver to the Company or such Shareholder Offeree, as the case may be, such documentation as the Company or such Shareholder Offeree shall reasonably
request to evidence the Transfer of such offered shares, against payment therefor by the Company or such Shareholder Offeree. 

        (iv)  In
the event that, after compliance with the foregoing provisions of this Section 3.1(c), the Company and the
Shareholder Offerees, taken together, fail to purchase all of the shares of Class B Common Stock proposed to be Transferred by the Transferor Shareholder, then for a period of 60 days
commencing on the date that neither the Company nor any Shareholder Offeree remains entitled to exercise its right to purchase any offered shares in accordance with the foregoing provisions of this  Section 3.1(c),
 the Transferor Shareholder may Transfer to the Proposed Purchaser all of the shares described in the Notice of Transfer;  provided, however, that any such Transfer to the Proposed Purchaser must be made for the consideration
and upon the terms and conditions set forth in the Notice of Transfer. If the Transferor Shareholder shall not consummate the Transfer of such shares to the Proposed Purchaser within such
60-day period, such shares shall remain subject to the provisions of this Agreement and the Transferor Shareholder shall not thereafter Transfer any such shares to any person without again
first complying with all of the provisions of this Agreement. 

        (d)   As
used herein, (i) prior to the automatic separation of the IDSs pursuant to the terms thereof,"Permitted
Transferee" shall mean any person other than a holder of the Company's Class A
Common Stock, including a holder of Class A Common Stock held as part of an IDS, or the Company's or Merisant Company's long-term indebtedness in any form, including, without
limitation, the Senior Subordinated Notes, whether held as Separate Senior Subordinated Notes or as part of an IDS, and (ii) after the automatic separation of the IDSs pursuant to the terms
thereof, "Permitted Transferee" shall mean any person. 

        3.2    Legend.    Each certificate evidencing
any shares of Class B Common Stock, unless such transfer is pursuant to a registered public offering of the Class B Common Stock, in which case the first paragraph below shall not apply,
shall bear the following legend in addition to any other legend required under applicable law: 

	

"THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS IT HAS BEEN REGISTERED UNDER SUCH ACT AND ALL SUCH APPLICABLE LAWS OR ANY EXEMPTION
FROM REGISTRATION IS AVAILABLE."
	

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE SECURITYHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. THE SALE, TRANSFER OR OTHER
DISPOSITION OF THE SECURITIES IS SUBJECT TO THE TERMS OF SUCH AGREEMENT AND THE SECURITIES ARE TRANSFERABLE ONLY UPON PROOF OF COMPLIANCE THEREWITH."

        3.3    Notation.    A
notation will be made in the appropriate transfer records of the Company with respect to the restrictions on transfer of the Class B Common Stock referred to in this Agreement. 

        3.4    Limitation on Repurchase of Shares of Class B Common Stock and Dividend
Payments.    Each Shareholder understands that the Company has entered into certain financing and other agreements 

6

 

which
contain prohibitions, restrictions and limitations on the ability of the Company to purchase any of the shares of Class B Common Stock and IDSs (including the shares of Class A
Common Stock and the Senior Subordinated Notes comprising the IDSs) and, under certain circumstances, to pay dividends on the Common Stock. 

Article IV

 Corporate Actions  

        4.1    Directors.    For so long as the LLC is
the beneficial owner (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) of at least 5% of the outstanding shares of Common Stock in the
aggregate on a fully-diluted basis and as a result the LLC has the right to elect two directors in accordance with the Amended and Restated Certificate of Incorporation of the Company, each
Shareholder and Permitted Transferee agrees that it shall take, at any time and from time to time, all action necessary (including voting the Class B Common Stock
owned by him, her or it, calling special meetings of shareholders and executing and delivering written consents) to ensure that the Board at all times includes two individuals designated by the LLC. 

        4.2    Right to Remove Certain of the Company's
Directors.    The LLC may request that any director designated by it be removed (with or without cause) by written notice to the other
Shareholders, and, in any such event, each Shareholder shall promptly consent in writing or vote or cause to be voted all shares of Class B Common Stock now or hereafter owned or controlled by
it for the removal of such person as a director. In the event any person ceases to be a director, such person shall also cease to be a member of any committee of the Board. 

        4.3    Right to Fill Certain Vacancies in the
Board.    In the event that a vacancy is created on the Board at any time by the death, disability, retirement, resignation or removal (with
or without cause) of a director designated by the LLC and elected by the holders of Class B Common Stock, or if otherwise there shall exist or occur any vacancy on the Board in a directorship
subject to designation by the LLC and election by the holders of Class B Common Stock, such vacancy shall not be filled by the remaining members of the Board, but each Shareholder hereby agrees
promptly to consent in writing or vote or cause to be voted all shares of Class B Common Stock now or hereafter owned or controlled by it to elect that individual designated to fill such
vacancy and serve as a director, as shall be designated by the LLC. 

        4.4    Confidentiality.    

        (a)   Each
Shareholder hereby agrees that Confidential Information (as defined below) has been and may be made available to him or it in connection with such Shareholder's
interest in the Company and its subsidiaries. Each Shareholder agrees that he or it will not use the Confidential Information in any way that is reasonably likely to result in a material detriment to
the business of the Company and its subsidiaries. Each Shareholder further acknowledges and agrees that he or it will not disclose any Confidential Information to any person;  provided, that Confidential
Information may be disclosed (i) to such Shareholder's Representatives (as defined below) in the normal course of the
performance of their duties, (ii) to the extent required by applicable statute, law, rule or regulation (including complying with any oral or written questions, interrogatories, requests for
information or documents, subpoena, civil investigative demand or similar process to which a Shareholder is subject) or by generally accepted accounting principles, (iii) to any third party to
whom such Shareholder is contemplating a transfer of his or its shares of Class B Common Stock, provided that such transfer would not be in
violation of the provisions of this Agreement and as long as such third party is advised of the confidential nature of such information and agrees to be bound by a confidentiality agreement in form
and substance satisfactory to the Company and substantially similar to the provisions hereof or (iv) if the prior consent of the Board shall have been obtained. Nothing contained herein shall
prevent the use of 

7

 

Confidential
Information in connection with the assertion or defense of any claim by or against the Company or any Shareholder. 

        (b)   "Confidential Information" means any information concerning the Company, its financial condition, business, subsidiaries,
operations or prospects in the possession of or to be furnished to any Shareholder in his or its capacity as a shareholder of the Company or by virtue of his or its present or former position as, or
right to designate, a director of the Company; provided, that the term "Confidential Information" does not include information which (a) was or
becomes generally available publicly other than as a result of a disclosure by a Shareholder or his or its partners, directors, officers, employees, agents, counsel, investment advisers, accountants,
consultants or representatives (all such persons being collectively referred to as "Representatives") in violation of this  Section 4.4(b) or,
(b) was or becomes available to such Shareholder on a nonconfidential basis from a source other than the Company, any
regulatory entity or a Shareholder or his or its Representatives, provided that such source is or was (at the time of receipt of the relevant
information) not, to the best of such Shareholder's knowledge, bound by a confidentiality agreement with the Company or another person. 

Article V

 Registration Rights  

        The Shareholders shall have registration rights with respect to the IDSs or Class A Common Stock and Senior Subordinated Notes to be received upon the
exchange of the Class B Common Stock as set forth in the Registration Rights Agreement attached hereto as Exhibit D (the
"Registration Rights Agreement"). Each of the Shareholders agrees not to effect any public sale or public distribution of any securities of the Company
during the periods specified in the Registration Rights Agreement, except as permitted thereby, and each such Shareholder agrees to be bound by the rights of priority to participate in offerings as
set forth therein. 

8

 
Article VI

 Exchange of Class B Common Stock for IDSs  

        6.1    Exchange of Class B Common Stock for
IDSs.    

        (a)   Shares
of Class B Common Stock shall be exchangeable for IDSs at the option of the holder thereof on any Exchange Date (as defined below) at the Exchange Rate (as
defined below); provided, however, that (i) until the date that is one year from the effective
date hereof, shares of Class B Common Stock shall not be exchangeable for IDSs, and (ii) until the date that is two years from the effective date hereof, shares of Class B Common
Stock designated as Restricted Shares on Exhibit A shall not be exchangeable for IDSs. Notwithstanding anything in this Article VI to the
contrary other than Section 6.1(e) and (f), no Shareholder shall have any right to exchange, and the Company may not exchange, any shares of Class B Common Stock for IDSs: (i) if
such exchange does not comply with applicable laws, including, without limitation, securities laws, laws relating to redemption of common stock and laws relating to the issuance of debt,
(ii) unless the IDSs (and/or the shares of Class A Common Stock and the Senior Subordinated Notes comprising the IDSs) issuable upon such exchange have been registered under the
Securities Act if such registration is required pursuant to the Amended and Restated Bylaws of the Company or the Securities Act, (iii) if such exchange conflicts with or causes a default under
any material financing agreement, (iv) if such exchange causes a mandatory suspension of dividends or deferral of interest under any material financing agreement as of the measurement date
immediately following the date of the proposed exchange, or (v) so long as an event of default or deferral of interest has occurred and is continuing under the indenture governing the Senior
Subordinated Notes. Any IDSs for which shares of Class B Common Stock have been exchanged pursuant hereto prior to the date that is two years from the effective date hereof shall be sold or
otherwise transferred by the Shareholder making such exchange in a public offering or otherwise to a person who is not an affiliate of such Shareholder within 30 days after the date of such
exchange. If such sale or other transfer is not consummated within such period, the Company and the Shareholder shall rescind such exchange unless such rescission falls under clause (i),
(iii) or (iv) above. 

        (b)   To
exercise the exchange right, the holder of Class B Common Stock to be exchanged shall surrender the certificate representing such Class B Common Stock,
duly endorsed or assigned to the Company or in blank, at the principal office of the Transfer Agent (as hereinafter defined) accompanied by written notice to the Company that such holder elects to
exchange such Class B Common Stock. Unless the IDSs issuable on exchange are to be issued in the same name as the name in which the Class B Common Stock is registered, in which case the
Company shall bear the related taxes, each share surrendered for exchange shall be accompanied by instruments of transfer, in form and substance satisfactory to the Company, duly executed by the
holder or such holder's duly authorized attorney and an amount sufficient to pay any transfer or similar tax (or evidence reasonably satisfactory to the Company demonstrating that such taxes have been
paid). 

        (c)   Each
exchange consummated pursuant to this Section 6.1 shall be deemed to have been effected immediately prior to
the close of business on the applicable Exchange Date, provided that certificates representing shares of Class B Common Stock shall have been
surrendered and such notice (and if applicable, payment of an amount equal to the distribution payable on such shares) received by the Company as aforesaid, and the person or persons in whose name or
names any certificate or certificates representing IDSs shall be issuable upon such exchange shall be deemed to have become the holder or holders of record of the shares and Senior Subordinated Notes
represented thereby at such time on such Exchange Date, and such exchange shall be at the Exchange Rate in effect at such time and on such date unless the stock transfer records of the Company for the
Class B Common Stock shall be closed on that date, in which event such person or persons shall be deemed to have become such holder or holders of record at the close of 

9

 

business
on the next succeeding day on which such stock transfer records for the Class B Common Stock are open, but such exchange shall be at the Exchange Rate in effect on the date on which
such shares have been surrendered and such notice received by the Company. 

        (d)   As
promptly as practicable after the surrender of the certificates representing the Class B Common Stock as aforesaid, the Company shall issue and deliver at such
office to such holder, or on his written order, certificates representing the full number of shares of Class A Common Stock and Senior Subordinated Notes represented by the IDSs issuable upon
the exchange of such shares of Class B Common Stock in accordance with the provisions of this Section 6.1, and any fractional interest
shall be settled as provided by Section 6.2 below. 

        (e)   Notwithstanding
anything to the contrary contained in this Agreement, in the event of a redemption by the Company of 100% of the Senior Subordinated Notes such that
following the redemption there will no longer be any Senior Subordinated Notes and IDSs outstanding, the Company shall give notice to the holders of the Class B Common Stock at least
30 days but not more than 60 days prior to such redemption date (the "Notes Redemption Date"). Notwithstanding any restrictions on exchange set
forth in this Agreement, if the Company redeems all of the Senior Subordinated Notes outstanding, all outstanding shares of the Class B Common Stock will be automatically (and without any
action required on the part of the holders of the Class B Common Stock) exchanged on the Notes Redemption Date for IDSs at the Exchange Rate, and the Senior Subordinated Notes acquired by the
holders of the Class B Common Stock as part of the IDSs in such exchange shall be redeemed by the Company as part of such redemption. 

        (f)    Notwithstanding
anything to the contrary contained in this Agreement, following the maturity date of the Senior Subordinated Notes, and during any period in which there
are otherwise no longer any Senior Subordinated Notes and IDSs outstanding (other than in connection with a redemption of 100% of the Senior Subordinated Notes), the holders of Class B Common
Stock shall have the right to exchange their shares of Class B Common Stock for shares of Class A Common Stock on a one-for-one basis, except as adjusted pursuant
to Section 6.3. 

        6.2    No Fractional IDSs.    No fractional
portion of an IDS (or shares of Class A Common Stock or Senior Subordinated Notes comprising the IDS) shall be issued upon exchange of Class B Common Stock. Instead of any fraction of an
IDS (or shares of Class A Common Stock or Senior Subordinated Notes comprising the IDS) that would otherwise be deliverable upon the exchange of Class B Common Stock, the Company shall
pay to the holder of such shares an amount in cash in respect of such fractional interest based upon the Fair Market Value (as defined below) of IDSs on the Trading Day (as defined below) immediately
preceding the Exchange Date. 

        6.3    Exchange Rate Adjustments.    

        (a)   The
Exchange Rate shall be adjusted from time to time as follows: 

          (i)  If
the Company shall after the date hereof: 

        (1)   pay
or make a distribution to holders of Class A Common Stock in the form of shares of Class A Common Stock or Class B Common Stock; 

        (2)   subdivide
its outstanding Class A Common Stock or Class B Common Stock into a greater number of shares of Class A Common Stock or Class B
Common Stock; 

        (3)   combine
its outstanding Class A Common Stock or Class B Common Stock into a smaller number of shares of Class A Common Stock or Class B
Common Stock; 

        (4)   issue
any equity securities by reclassification of its Class A Common Stock or Class B Common stock (other than any reclassification by way of merger or
binding share exchange that is subject to Section 6.3(b)); or 

10

 

        (5)   issue
rights, options or warrants to all holders of Class A Common Stock entitling them to subscribe for or purchase IDSs, Class A Common Stock and/or
Class B Common Stock at a price per share less than the Fair Market Value per share of IDSs, Class A Common Stock or Class B Common Stock on the record date for the determination
of stockholders entitled to receive such rights, options or warrants; 

        then
the Exchange Rate in effect at the opening of business on the day following the record date for the determination of stockholders entitled to receive such distribution or at the
opening of business on the day following the day on which such subdivision, combination or reclassification becomes effective, as the case may be, shall be adjusted so that the holder of any share of
Class B Common Stock thereafter surrendered for exchange shall be entitled to receive the number of IDSs (including the number of shares of Class A Common Stock and the principal amount
of Senior Subordinated Notes comprising the IDSs) and other equity securities issued by reclassification of Class A Common Stock or Class B Common Stock that such holder would have owned
or have been entitled to receive after the happening of any of the events described above had such shares been exchanged immediately prior to the record date in the case of a distribution or the
effective date in the case of a subdivision, combination or reclassification. An adjustment made pursuant to this subparagraph (i) shall become effective immediately after the opening of
business on the day following such record date (except as provided in Section 6.3(e)) in the case of a distribution and shall become effective immediately after the opening of business on the
day next following the effective date in the case of a subdivision, combination or reclassification. 

         (ii)  Except
as provided in clause (i) of this Section 6.3(a), if the Company shall after the date of consummation of the Offering issue or sell shares of
Class A Common Stock (or securities convertible into or exchangeable for shares of Class A Common Stock) at a price per share of Class A Common Stock less than the Fair Market
Value per share of Class A Common Stock on the date of issuance or sale, then the Exchange Rate in effect immediately prior to the issuance or sale shall be adjusted as the Board determines to
be equitable in the circumstances. Such adjustment shall become effective immediately after the opening of business on the day following such issuance or sale. In determining whether any such issuance
or sale would allow a person or entity to subscribe for or purchase shares of Class A Common Stock at less than the Fair Market Value, the value of any consideration received by the Company
upon such sale other than cash shall be determined by the Board. 

        (iii)  No
adjustment in the Exchange Rate shall be required unless such adjustment would require a cumulative increase or decrease of at least 1% in the Exchange Rate;  provided, however, that any adjustments that by reason of this subparagraph (iii) are not
required to be made shall be carried forward and taken into account in any subsequent adjustment until made; and provided,  further, that any adjustment
shall be required and made in accordance with the provisions of this Section 6.3 (other than this subparagraph
(iii)) not later than such time as may be required in order to preserve the tax-free nature of a distribution to the holders of IDSs. All calculations under this Section 6.3 shall
be made to the nearest cent (with $.005 being rounded upward) or to the nearest one-tenth of a share (with .05 of a share being rounded upward), as the case may be. Anything in this
subsection (a) to the contrary notwithstanding, the Company shall be entitled, to the extent permitted by law, to make such increases in the Exchange Rate, in addition to those required by this
subsection (a), as it in its discretion shall determine to be advisable in order that any share distributions, subdivision, reclassification or combination of shares, distribution of rights, options
or warrants to purchase shares or securities, or a distribution of other assets (other than cash distributions) hereafter made by the Company to its shareholders shall not be taxable. 

        (b)   Except
as otherwise provided for in Section 6.3(a)(i), if the Company shall be a party to any transaction (including, without limitation, a merger, consolidation,
statutory share exchange, 

11

 

tender
offer for all or substantially all of the IDSs or Class A Common Stock, sale or transfer of all or substantially all of the Company' assets or recapitalization of the IDSs or
Class A Common Stock) (each of the foregoing being referred to herein as a "Transaction"), in each case as a result of which IDSs or
Class A Common Stock shall be converted into the right to receive shares, stock, securities or other property (including cash or any combination thereof), the Company (or its successor in such
Transaction) shall make appropriate provision so that each share of Class B Common Stock, if not converted into the right to receive shares, stock, securities or other property in connection
with such Transaction in accordance with the third to last sentence of this subsection (b) shall thereafter be exchangeable into the kind and amount of shares, stock, securities and other
property (including cash or any combination thereof) receivable upon the consummation of such Transaction by a holder of that number of IDSs into which one share of Class B Common Stock was
convertible immediately prior to such Transaction, assuming such holder of Common Stock (i) is not a person with which the Company consolidated or into which the Company merged or which merged
into the Company or to which such sale or transfer was made, as the case may be (a "Constituent Person"), or an affiliate of a Constituent Person and
(ii) failed to exercise his rights of the election, if any, as to the kind or amount of shares, stock, securities and other property (including cash or any combination thereof) receivable upon
such Transaction (each, a "Non-Electing Share") (provided that if the kind and amount of shares, stock, securities and other property
(including cash or any combination thereof) receivable upon consummation of such Transaction is not the same for each Non-Electing Share, the kind and amount of shares, stock, securities
and other property (including cash or any combination thereof) receivable upon such Transaction by each Non-Electing Share shall be deemed to be the kind and amount so receivable per share
by a plurality of the Non-Electing Shares). The Company shall not be a party to any Transaction in which any share of Class B Common Stock is converted into the right to receive
shares, stock, securities or other property (including cash or any combination thereof) with an aggregate value (as determined by the Board in good faith, whose determination shall be conclusive) less
than that receivable by the number of shares of IDSs into which shares of Class B Common Stock were exchangeable immediately prior to such Transaction. The Company shall not be a party to any
Transaction unless the terms of such Transaction are consistent with the provisions of this subsection (b), and it shall not consent or agree to the occurrence of any Transaction until the Company has
entered into an agreement with the successor or purchasing entity, as the case may be, for the benefit of the holders of the Class B Common Stock that will contain provisions enabling holders
of Class B Common Stock that remains outstanding after such Transaction to exchange their Class B Common Stock into the consideration received by holders of IDSs at the Exchange Rate in
effect immediately prior to such Transaction. The provisions of this subsection (b) shall similarly apply to successive Transactions. 

        (c)   If:

          (i)  the
Company shall declare a distribution (other than cash distributions which do not constitute extraordinary dividends) on the Class A Common Stock in the form
of shares of Class A Common Stock or Class B Common Stock, or there shall be a reclassification, subdivision or combination of the Class A Common Stock or Class B Common
Stock; or 

         (ii)  the
Company shall grant to the holders of Class A Common Stock rights, options or warrants to subscribe for or purchase IDSs, Class A Common Stock or
Class B Common Stock at less than Fair Market Value; or 

        (iii)  the
Company shall sell Class A Common Stock or securities convertible into Class A Common Stock for less than Fair Market Value; or 

        (iv)  the
Company shall enter into a Transaction; or 

12

 

         (v)  there
shall occur the voluntary or involuntary liquidation, dissolution or winding up of the Company; 

        then
the Company shall cause to be mailed to the holders of the Class B Common Stock at their addresses as shown on the stock transfer records of the Company, as promptly as
possible, but at least 15 days prior to the applicable date hereinafter specified, a notice stating (i) the date on which a record is to be taken for the purpose of such distribution or
rights, options or warrants, or, if a record is not to be taken, the date as of which the holders of Common Stock or IDSs of record to be entitled to such distribution or rights, options or warrants
are to be determined or (ii) the date on which such reclassification, subdivision, combination, Transaction or liquidation, dissolution or winding up is expected to become effective, and the
date as of which it is expected that holders of IDSs of record shall be entitled to exchange their IDS (or shares of Class A Common Stock or Senior Subordinated Notes comprising the IDSs) for
securities or other property, if any, deliverable upon such reclassification, subdivision, combination, Transaction or liquidation, dissolution or winding up. Failure to give or receive such notice or
any defect therein shall not affect the legality or validity of the proceedings described in this Section 6.3. 

        (d)   Whenever
the Exchange Rate is adjusted as herein provided, the Company shall promptly prepare a notice of such adjustment of the Exchange Rate setting forth the adjusted
Exchange Rate and the effective date such adjustment becomes effective and shall mail such notice of such adjustment of the Exchange Rate to the holder of each share of Class B Common Stock at
such holder's last address as shown on the stock transfer records of the Company. The inclusion of the Company's calculation of the adjusted Exchange Rate as set forth in such notice shall be
conclusive evidence of the correctness of such adjustment absent manifest error. 

        (e)   In
any case in which Section 6.3(a) provides that an adjustment shall become effective on the day following the record date for an event, the Company may defer
until the occurrence of such event (i) issuing to the holder of any share of Class B Common Stock converted after such record date and
before the occurrence of such event the additional IDSs issuable upon such conversion by reason of the adjustment required by such event over and above the shares of IDSs issuable upon such conversion
before giving effect to such adjustment and (ii) fractionalizing any share of Class B Common Stock and/or paying to such holder any amount of cash in lieu of any fraction pursuant to
Section 6.2. 

        (f)    There
shall be no adjustment of the Exchange Rate in case of the issuance of any equity securities of the Company in a reorganization, acquisition or other similar
transaction except as specifically set forth in this Section 6.3. If any action or transaction would require adjustment of the Exchange Rate pursuant to more than one subsection of
Section 6.3(a), only one adjustment shall be made, and such adjustment shall be the amount of adjustment that has the highest absolute value. 

        6.4    Related Covenants.    

        (a)   If
the Company shall take any action affecting the IDSs, Class A Common Stock or Class B Common Stock, other than the actions described in this
Article VI, that in the opinion of the Board would materially and adversely affect the exchange rights of the holders of Class B Common Stock, the Exchange Rate for the Class B
Common Stock shall be adjusted, to the extent permitted by law, in such manner, if any, and at such time, as the Board, in its sole discretion, determines to be equitable in the circumstances. If
there is an automatic separation of the IDSs at any time, the exchange rights of the holders of Class B Common Stock shall be adjusted, to the extent permitted by law, in such manner, if any,
and at such time, as the Board, in its sole discretion, determines to be equitable in the circumstances, provided that the conditions precedent set forth in  Section 6.1(a) shall continue to apply
to such exchange rights. 

13

 

        (b)   The
Company shall at all times reserve and keep available, free from preemptive rights, out of the aggregate authorized but unissued Class A Common Stock, for the
purpose of effecting the exchange of the Class B Common Stock, the full number of shares of Class A Common Stock deliverable upon the exchange of all outstanding shares of Class B
Common Stock not theretofore exchanged. For purposes of this subsection (b), the number of shares of Class A Common Stock that shall be deliverable upon the exchange of all outstanding shares
of Class B Common Stock shall be computed as if at the time of computation all outstanding shares were held by a single holder. 

        (c)   The
Company covenants that any shares of Class A Common Stock issued upon the exchange of Class B Common Stock for IDSs shall be validly issued, fully paid
and non-assessable. 

        (d)   The
Company shall list the IDSs required to be delivered upon exchange of the Class B Common Stock, prior to such delivery, upon each national exchange, if any,
upon which the outstanding IDSs are listed at the time of such delivery. 

        (e)   Prior
to the delivery of the IDSs (including the shares of Class A Common Stock and the Senior Subordinated Notes comprising the IDSs) that the Company shall be
obligated to deliver upon the exchange of the Class B Common Stock, the Company shall comply with all federal and state laws and regulations thereunder requiring registration of such securities
with, or any approval or consent to the delivery thereof, by any governmental authority. 

        (f)    The
Company shall pay any and all documentary stamp or similar issue or transfer taxes payable in respect of the issue and delivery of IDSs or other securities or
property on exchange of the Class B Common Stock pursuant hereto; provided, however, that the
Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issue or delivery of IDSs or other securities or property in a name other than that of the
record holder of the Class B Common Stock to be exchanged, and no such issue or delivery shall be made unless and until the person requesting such issue or delivery has paid to the Company the
amount of any such tax or established, to the reasonable satisfaction of the Company, that such tax has been paid. 

        6.5    Certain Defined Terms.    

        (a)   As
used herein the term "Current Market Price" of any IDS or equity security of the Company or any other issuer for any
day shall mean the last reported sales price, regular way, on such day, or, if no sale takes place on such day, the average of the reported closing bid and asked prices on such day, regular way, in
either case as reported on the Nasdaq National Market or, if such security is not listed or admitted for trading on the Nasdaq National Market, on the principal national securities exchange on which
such security is listed or admitted for trading or, if not listed or admitted for trading on any national securities exchange, the average of the closing bid and asked prices on such day in the
over-the-counter market. 

        (b)   As
used herein, the term "Exchange Date" shall mean any date on or after the first anniversary of the effective date
hereof or, with respect to the Restricted Shares, the date that is two years from the effective date hereof, and prior to the maturity date of the Senior Subordinated Notes and designated by the LLC
or, upon liquidation of the LLC, a majority of the holders of shares distributed upon such liquidation to the holders of any membership interests initially issued to Pegasus Partners II, L.P. under
the Amended and Restated Limited Liability Company Agreement, dated as of March 8, 2000, by and among the LLC and the members of the LLC, as amended from time to time (the
"Pegasus Shareholders") as an Exchange Date by providing not less than 15 days written notice to the Company and each of the other Shareholders;  provided, however, that (i) a date within 6 months of any previous Exchange Date may not
be designated as an Exchange Date and (ii) the LLC and the Pegasus Shareholders may not declare an Exchange Date if the number of shares of Class B Common Stock to be exchanged on such
Exchange Date 

14

 

is
less than the lesser of            shares or            % of the total number of shares of Class B Common Stock then
outstanding. 

        (c)   As
used herein the term "Exchange Rate" shall mean an amount equal to (i) the per IDS initial public offering
price of the IDSs less the principal amount of the Senior Subordinated Note comprising the IDSs divided by (ii) the per IDS initial public offering price of the IDSs, as adjusted from time to
time in accordance with this Article VI; 

        (d)   As
used herein the term "Fair Market Value" with respect to the IDSs or the Class A Common Stock shall mean the
average of the daily Current Market Prices per IDS or share of Class A Common Stock, as applicable, during the ten consecutive Trading Days selected by the Company commencing not more than 20
Trading Days before, and ending not later than, the earlier of the day in question and the day before the "ex-date" with respect to the issuance or distribution requiring such computation.
The term "ex-date," when used with respect to any issuance or distribution, means the first day on which the IDSs or Class A Common Stock, as applicable, trade regular way, without
the right to receive such issuance or distribution, on the exchange or in the market, as the case may be, for purposes of determining that day's Current Market Price. 

        (e)   As
used herein, the term "Trading Day" shall mean any day on which the securities in question are traded on the Nasdaq
National Market or, if such securities are not listed or admitted for trading on the Nasdaq National Market, on the principal national securities exchange on which securities are listed or admitted
or, if not listed or admitted for trading on any national securities exchange, on the applicable securities market in which such securities are traded. If such securities are not trading on any
securities market, the Board shall determine which day shall be deemed the Trading Day. 

        (f)    As
used herein, the term "Transfer Agent" shall mean Wells Fargo Bank, National Association or any successor transfer
agent of the Company's IDSs. 

Article VII

 Amendment and Restatement; Repurchase of Class B Common Stock  

        7.1    Amendment and Restatement of Existing Shareholders Agreement; Approvals of Offering
Transactions.    

        (a)   Each
party hereto agrees that, upon consummation of the Offering, (i) the Existing Shareholders Agreement shall be amended and restated and replaced in its
entirety with this Agreement and (ii) the terms of the Existing Shareholders Agreement shall cease to be of any effect. 

        (b)   Each
Shareholder consents and agrees to take all action necessary for the consummation of the Offering and the related transactions. 

        (c)   Each
party hereto consents to the amendment and restatement of the certificate of incorporation of the Company and to the amendment and restatement of the bylaws of the
Company, substantially in the forms as filed by the Company as exhibits to the Form S-1. 

        7.2    Repurchase Upon Offering.    Upon
consummation of the Offering (the "Initial Repurchase Date"), each of the LLC and the Initial Investors hereby sells, transfers and assigns to the
Company, and the Company hereby purchases from the LLC and such Initial Investor, free and clear of all liens, claims, security interests, pledges, charges, equities, options, restrictions and
encumbrances, the number of shares of Class B Common Stock set forth opposite the LLC's and such Initial Investor's name on Exhibit B. 

15

 

        7.3    Repurchase Upon Exercise of the Over-Allotment
Option.    

        (a)   Upon
exercise by the Underwriters of the Over-Allotment Option in full, each Shareholder hereby sells, transfers and assigns to the Company, and the Company
hereby purchases from such Shareholder, free and clear of all liens, claims, security interests, pledges, charges, equities,
options, restrictions and encumbrances, the number of shares of Class B Common Stock set forth opposite such Shareholder's name on  Exhibit C. 

        (b)   Upon
any partial exercise of the Over-Allotment Option, each Shareholder hereby sells, transfers and assigns to the Company, and the Company hereby purchases
from such Shareholder, free and clear of all liens, claims, security interests, pledges, charges, equities, options, restrictions and encumbrances, such pro rata number of shares of Class B
Common Stock of such Shareholder based on the number of shares of Class B Common Stock set forth opposite such Shareholder's name on  Exhibit C as will be purchased by the total proceeds
received by the Company in such partial exercise of the Over-Allotment Option. 

        (c)   Notwithstanding
Sections (a) and (b) above, if the Over-Allotment Option is exercised prior to the issuance of shares pursuant to the SAR Plan,
none of the Additional Investors will sell their shares of Class B Common Stock to the Company, and the Initial Investors will sell such pro rata number of shares of Class B Common Stock
of such Initial Investor based on the number of shares of Class B Common Stock set forth opposite such Initial Investor's name on  Exhibit C as will be purchased by the total proceeds received
by the Company in connection with such exercise of the Over-Allotment
Option. In such case, payments under the SAR Plan shall be adjusted accordingly as determined by the Compensation Committee of the Board. 

        7.4    Repurchase Price.    The per share
purchase price for the Class B Common Stock is an amount equal to the Exchange Rate multiplied by the per IDS initial public offering price of the IDSs. 

        7.5    Release From Liability.    Each of the
Shareholders hereby releases and discharges the Company from any and all claims and/or causes of action, known or unknown, arising from or relating to the Existing Common Stock, the Existing
Shareholders Agreement and with respect to any Class B Common Stock repurchased by the Company in accordance with this Article VII. 

Article VIII

 Miscellaneous  

        8.1    Specific Performance.    The Parties
agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is
accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions
of this Agreement in any court within the United States, this being in addition to any other remedy to which they are entitled at law or in equity. 

        8.2    Expenses.    All costs and expenses
incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the Party incurring such expense. 

        8.3    Entire Agreement; Amendments.    This
Agreement and the documents delivered pursuant hereto contain the entire understanding of the Parties hereto with regard to the subject matter contained herein or therein, and supersede all prior
agreements, understandings or letters of intent between or among any of the Parties hereto. This Agreement shall not be amended, modified or supplemented without the written consent of each of
(i) the Company, (ii) the LLC (which consent shall have been approved by members holding at least 80% of the membership interests if such amendment, modification or supplement adversely
affects the members as a whole; provided, however, that if such amendment, modification or supplement
specifically adversely affects a member (as 

16

 

opposed
to the members as a whole), the consent of such member shall be required unless such member is a "Defaulting Member" as defined in the Amended and Restated Limited Liability Company Agreement
of the LLC) and (iii) in the event that such amendment, modification or supplement adversely affects the Investors, the holders of a majority of the shares of Class B Common Stock then
held by the Investors. 

        8.4    Waivers.    Any term or provision of
this Agreement may be waived, or the time for its performance may be extended, by the Party or Parties entitled to the benefit thereof. Any such waiver shall be validly and sufficiently given for the
purposes of this Agreement if, as to any Party, it is in writing signed by an authorized representative of such Party. The failure of any Party hereto to enforce at any time any provision of this
Agreement shall not be construed to be a waiver of such provision, nor in any way to affect the validity of this Agreement or any part hereof or the right of any Party thereafter to enforce each and
every such provision. No waiver of any breach of this Agreement shall be held to constitute a waiver of any other or subsequent breach. 

        8.5    Partial Invalidity.    Wherever
possible, each provision hereof shall be interpreted in such manner as to be effective and valid under applicable law, but in case any one or more of the provisions contained herein shall, for any
reason, be held to be invalid, illegal or unenforceable in any respect, such provision shall be ineffective to the extent, but only to the extent, of such invalidity, illegality or unenforceability
without invalidating the remainder of such provision or provisions or any other provisions hereof, unless such a construction would be unreasonable. 

        8.6    Execution in Counterparts.    This
Agreement may be executed in counterparts, each of which shall be considered an original instrument, but all of which shall be considered one and the same agreement,
and shall become binding when one or more counterparts have been signed by each of the Parties hereto and delivered to each of the Parties hereto. 

        8.7    Governing Law.    This Agreement shall
be governed by and construed in accordance with the internal laws (as opposed to the conflicts of law provisions) of the State of Delaware. 

        8.8    Further Assurances.    Each Party shall
cooperate and take such action as may reasonably be requested by another Party in order to carry out the provisions and purposes of this Agreement and the transactions contemplated hereby. 

        8.9    Successors and Assigns.    All
covenants and agreements in this Agreement by or on behalf of any of the Parties hereto shall bind and inure to the benefit of the respective successors and assigns of the Parties hereto whether so
expressed or not. 

        8.10    Descriptive Headings; Interpretation; No Strict
Construction.    The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive part of this
Agreement. Whenever required by the context, any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and singular forms of nouns, pronouns, and verbs
shall include the plural and vice versa. Reference to any agreement, document, or instrument means such agreement, document, or instrument as amended or otherwise modified from time to time in
accordance with the terms thereof, and if applicable hereof. The use of the words "include," "includes" or "including" in this Agreement shall be by way of example rather than by limitation. The use
of the words "or," "either" or "any" shall not be exclusive. The Parties have participated jointly in the negotiating and drafting of this Agreement. In the event an ambiguity or question of intent or
interpretation arises, this Agreement shall be construed as if drafted by each of the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the
authorship of any of the provisions of this Agreement. 

        8.11    Notices.    All notices, demands or
other communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given when (a) delivered personally to
the recipient, (b) faxed to the recipient (with hard copy sent to the 

17

 

recipient
by reputable overnight courier service (charges prepaid) that same day) if faxed before 5:00 p.m. New York City time on a business day, and otherwise on the next business day, or
(c) one business day after being sent to the recipient by reputable overnight courier service (charges prepaid). Such notices, demands and other communications shall be sent to the Company at
the address set forth below and to the other Parties at such address as indicated by the Company's records, or at such address or to the attention of such other person as the recipient Party has
specified by prior written notice to the sending Party. The Company's address is: 

10
S. Riverside Plaza, Suite 850

Chicago, Illinois 60606

Attention: General Counsel

Telephone: (312) 840-6000

Fax: (312) 840-5541 

        8.12    Delivery by Facsimile.    This
Agreement, the agreements referred to herein, and each other agreement or instrument entered into in connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or
thereto, to the extent signed and delivered by means of a facsimile machine, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same
binding legal effect as if it were the original signed version thereof delivered in person. At the request of any party hereto or to any such agreement or instrument, each other party hereto or
thereto shall re-execute original forms thereof and deliver them to all other parties. No party hereto or to any such agreement or instrument shall raise the use of a facsimile machine to
deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine as a defense to the formation or enforceability of
a contract and each such party forever waives any such defense. 

        8.13    Party No Longer Owning Shares of Class B Common
Stock.    If a Party ceases to own any shares of Class B Common Stock and to have any right to purchase or receive any shares of
Class B Common Stock, such Party will no longer be deemed to be a Shareholder for purposes of this Agreement and shall not be bound by the terms hereof. 

        8.14    Term.    This Agreement shall continue
at all times hereafter and terminate only upon the date on which no shares of Class B Common Stock remain outstanding. Sections 1.1(d) and (e) and Sections 2.1(c) and (d) shall
terminate on the date on which the IDSs automatically separate pursuant to the terms thereof. 

*            *            *            *    
        *

18

        IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above. 

	 	 	MERISANT WORLDWIDE, INC.
	

 	
 	

By:	

  

	 	 	Name:	 
	 	 	Its:	 
	

 	
 	
TABLETOP HOLDINGS, LLC
	

 	
 	

By:	

  

	 	 	Name:	 
	 	 	Its:	 
	

 	
 	
INITIAL INVESTORS:
	

 	
 	

  
 Arnold Donald
	

 	
 	

  
 Jerry Knock
	

 	
 	

  
 Ed Flowers
	

 	
 	

  
 Karl Sestak
	

SIGNATURE PAGE TO AMENDED AND RESTATED SHAREHOLDERS AGREEMENT
	 	 	 	 

	

 	
 	

  
 Roberto Mourey
	

 	
 	

  
 Steve Adolph
	

 	
 	

  
 Joann Digman
	

 	
 	

  
 Barb Jones
	

 	
 	

  
 Thomas Verbeke
	

 	
 	

  
 Robert Border
	

 	
 	

  
 Richard Federer
	

 	
 	

  
 Ken Jones
	

SIGNATURE PAGE TO AMENDED AND RESTATED SHAREHOLDERS AGREEMENT
	 	 	 	 

	

 	
 	

  
 Lincoln D. Germain
	

 	
 	

  
 John Sheptor
	

 	
 	

  
 Michael G. Nichols
	

 	
 	

  
 Luther C. Kissam, IV, as Trustee of the

Luther C. Kissam IV Trust
	

 	
 	

  
 Etienne J. Veber, as Trustee of the

Etienne J. Veber Trust
	

 	
 	

  
 Jane Boyce
	

 	
 	

  
 Dana Voris
	

SIGNATURE PAGE TO AMENDED AND RESTATED SHAREHOLDERS AGREEMENT
	 	 	 	 

	

 	
 	

  
 Carl W. Warschausky, as Trustee of the

Carl W. Warschausky Trust
	

 	
 	
J.H. WHITNEY MEZZANINE FUND, L.P.
	

 	
 	

By:	

Whitney GP, L.L.C.,

its General Partner
	

 	
 	

By:	

  

	

 	
 	

Name:	

 
	 	 	A Managing Member
	

 	
 	
J.H. WHITNEY MARKET VALUE FUND, L.P.
	

 	
 	

By:	

Whitney Market Value GP, Ltd.,

its General Partner
	

 	
 	

By:	

  

	

 	
 	

Name:	

 
	 	 	A Managing Member
	

 	
 	
THE NORTHWESTERN MUTUAL LIFE

    INSURANCE COMPANY
	

 	
 	

By:	

  

	 	 	Name:	 
	 	 	Its:	 
	

SIGNATURE PAGE TO AMENDED AND RESTATED SHAREHOLDERS AGREEMENT
	 	 	 	 

	

 	
 	
GARMARK PARTNERS, L.P.
	

 	
 	

By:	

GarMark Associates L.L.C.,

its General Partner
	

 	
 	
 
	

 	
 	

By:	

  
 Authorized Signatory
	

 	
 	

By:	

  
 Authorized Signatory
	

 	
 	
ADDITIONAL INVESTORS:
	

 	
 	

  
 Chris Sinclair
	

 	
 	

  
 Dan Beck
	

 	
 	

  
 Ellen Hoffing
	

 	
 	

  
 Lyle Sajewich
	

 	
 	

  
 Randy Jackson
	

SIGNATURE PAGE TO AMENDED AND RESTATED SHAREHOLDERS AGREEMENT

QuickLinks

FORM OF AMENDED AND RESTATED SHAREHOLDERS AGREEMENTQuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.8    
    

CONFIDENTIAL MATERIAL APPEARING IN THIS DOCUMENT WAS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION IN ACCORDANCE WITH RULE 24b-2,
PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. OMITTED INFORMATION WAS REPLACED WITH ASTERISKS.  

 SECOND AMENDED AND RESTATED SUPPLY AGREEMENT  

        THIS SECOND AMENDED AND RESTATED SUPPLY AGREEMENT (this
"Agreement") is made as of this 31st day of December, 2003, by and between Merisant Company, a Delaware corporation, having its principal
place of business at 10 S. Riverside Plaza, Chicago, IL 60606 ("Merisant"), Merisant Company 1 Sarl, a company organized under the laws of Switzerland,
having its principal place of business at Avenue J. J. Rousseau 7, 2000 Nechatel, Switzerland ("Swissco" and, together with Merisant,
"Buyer"), and The NutraSweet Company, a Delaware corporation, having its principal place of business at 200 World Trade Center, The Merchandise Mart,
Suite 936, Chicago, IL 60654 ("NSC"). 

RECITALS:  

        WHEREAS, Buyer, as successor to Tabletop Sweetener, LP, and NSC, as successor to Monsanto Company, are parties to
that certain Amended and Restated Supply Agreement, dated February 3, 2000, as amended and supplemented by that certain  First Addendum to Amended and Restated Supply
Agreement, dated November 1, 2002, and further amended and supplemented by that certain  Second Addendum to Amended and Restated Supply Agreement, dated July 17, 2003
(collectively, the "Original
Agreement"), pursuant to which NSC has agreed to supply Buyer's requirements for aspartame for use in the manufacture, marketing, distribution and sale of tabletop sweetener
products to consumer end-users and establishments serving or selling to such consumer end-users (including any successor thereto, the
"Business") through December 31, 2004. 

        WHEREAS, certain affiliates and designees of Merisant have been purchasing from NSC under the Original Agreement; 

        WHEREAS, Merisant and NSC desire to add Swissco as a party to this Agreement to clarify the purchasing arrangements hereunder; 

        WHEREAS, Buyer and NSC have agreed that, subject to the terms and conditions and during the term set forth herein, NSC will sell to Buyer,
and Buyer will buy from NSC, aspartame for continued use in the Business on the amended and restated terms set forth herein. 

THE
PARTIES HAVE AGREED: 

        1.     Supply of aspartame. During the Term (as defined below), NSC agrees to sell and cause its affiliates to sell, and Buyer
agrees to buy, or cause the Business to buy (through Buyer's Affiliates or designees), aspartame manufactured in accordance with the specifications set forth in  Exhibit A attached hereto
("Powder Product") and, solely during calendar year 2005, aspartame
manufactured in accordance with the specifications set forth in Exhibit B attached hereto ("Fine Granular
Product" and, together with the Powder Product, the "Product") (the specifications set forth on  Exhibits A and B referred to herein as the
"Specifications"). 

        2.     Term. Unless earlier terminated as provided in paragraph 4 of  Exhibit C attached hereto or in this Section 2, this Agreement shall be in effect for the
period commencing on the date hereof and ending
on December 31, 2005 (the "Term"). 

        3.     Purchase/Use.

        (a)   During
the Term of this Agreement, subject to the terms hereof, Buyer agrees to buy, or cause the Business to buy, from NSC, and NSC agrees to sell or cause to be sold
to Buyer or the Business, the number of pounds of Product set forth on Exhibit D. During calendar year 2004, NSC shall be the Buyer's exclusive
supplier of aspartame for use in tabletop sweetener products 

 

manufactured
by or for Buyer and its Affiliates for sale in the Territory (as defined below), and Buyer shall not purchase aspartame from any other person for use in such products. Product purchased
under the terms of this Agreement may be used in tabletop sweetener products manufactured by Buyer and its Affiliates that are sold only in those areas of the world, set forth in  Exhibit D (the
"Territory"). Notwithstanding the foregoing, if NSC is unable, because of legal,
regulatory or contractual constraints, or otherwise fails, to supply a sufficient amount of Product to Buyer to meet its requirements in the Territory, then Buyer shall be permitted to buy Product
from a third-party supplier for use in the Territory for so long as such inability or failure exists. 

        (b)   Upon
execution of this Agreement, and thereafter at least sixty (60) days prior to the commencement of each succeeding calendar quarter during the Term, Buyer
shall provide NSC with a non-binding forecast of the quantity of Product that Buyer estimates the Business will require in the Territory for the immediately succeeding calendar quarter and
the next succeeding three (3) calendar quarters. At least thirty (30) days prior to the commencement of each calendar month during the Term, Buyer shall provide NSC with a firm order for
the quantities of Product the Business will require in the Territory during such calendar month, and NSC will timely fill such order. During the Term, Buyer and NSC shall meet as regularly as
necessary to discuss the schedule of production and deliver so as to ensure that all quantities agreed to for each calendar year are ordered and delivered in a predictable, orderly manner throughout
such year. 

        4.     Price. The prices for Product during the Term are set forth on Exhibit D attached hereto. 

        5.     Terms and Conditions. This Agreement shall also be governed by the Other Terms and Conditions set forth on  Exhibit C attached hereto. In the event of any conflict
or inconsistency between the other terms and conditions set forth on  Exhibit C attached hereto and the terms and conditions within the body of this Agreement, the terms and conditions within the
body of this
Agreement shall control. 

        6.     License of Use of NutraSweet Logo on Packaging. Buyer acknowledges that it shall have no rights to any "NutraSweet"
trademarks or "Swirl" designs other than as expressly set forth in (a) the Amended and Restated Trademark License Agreement, dated March 17, 2000, by and between NSC and
Tablesweet Inc. and (b) the Amended and Restated Trademark Sub-License Agreement, dated March 17, 2000, by and between Tablesweet Inc. and Tabletop Sweetener,
L.P. 

        7.     Confidentiality. (a) Except, upon prior notice to the other party, to a governmental agency in response to any
written demand by such agency pursuant to applicable law or to governmental health authorities to obtain and maintain the registration of aspartame, a party receiving confidential information
hereunder shall not, without the specific written consent of the other party, disclose to any third party or use for its own purposes any information which is received from the disclosing party,
including, without limitation, the price and similar terms of this Agreement, unless such information: 

        (i)    is
or becomes generally available to the public other than through the action of the receive party, its agents or employees; 

        (ii)   was,
at the time of receipt by the receiving party, already in the receiving party's possession as evidenced by its written records; or 

        (iii)  was
obtained by the receiving party from a third party legally entitled to use and disclose the same. 

Notwithstanding
the foregoing, (1) Buyer or its Affiliates may disclose this Agreement and any of the terms (other than volume, price and territory information set out on  Exhibit D) hereunder (A) as
required by the Indenture dated as of July 11, 2003 by and among Merisant Company, the guarantors from
time to time a party thereto and Wells Fargo Bank Minnesota, National Association, as Trustee; (B) as required by the Indenture dated as of November11, 2003 by and between Tabletop 

2

 

Holdings, Inc.
and Wells Fargo Bank Minnesota, National Association, as Trustee; and (C) as required by the Securities Act of 1933 (the "Securities
Act") or the Securities Exchange Act of 1934 (the "Exchange Act") and the rules and regulations promulgated thereunder; provided
that any description of this Agreement included in any document provided to any third party is subject to the prior approval of the other party, which approval will not be unreasonably delayed or
withheld; and (2) either party hereto may disclose this Agreement and any of the terms hereunder (A) to a potential buyer in connection with the sale, directly or indirectly, of all or
substantially all of such party's business, or (B) to any creditor or prospective creditor of such party or its Affiliates (or any agent on behalf thereof) in connection with such creditor's or
prospective creditor's due diligence and/or review of such party's or such Affiliate's books and records. 

        (b)   Notwithstanding
anything herein to the contrary, confidential information shall not include, and each of the parties and their respective Affiliates (and the respective
partners, directors, officers, employees, advisors, representatives and other agents of each of the foregoing and their Affiliates) may disclose to any and all persons, without limitation of any kind,
(i) any information with respect to the U.S. federal and state income tax treatment of the transactions contemplated hereby and any facts that may be relevant to understanding such tax
treatment, which facts shall not include for this purpose the names of the parties or any other person named herein, or information that would permit identification of the parties or such other
persons, or any pricing terms or other nonpublic business or financial information that is unrelated to such tax treatment or facts, and (ii) all materials of any kind (including opinions or
other tax analyses) relating to such tax treatment or facts that are provided to any of the persons referred to above, and it is hereby confirmed that each of the persons referred to above has been
authorized to make such disclosures since the commencement of discussions regarding the transactions contemplated hereby. 

        8.     Release. Each of the parties hereto does for itself and on behalf of each of its subsidiaries, representatives, officers,
directors, employees, agents, Affiliates, predecessors, successors and/or assigns, hereby release, remise and forever discharge the other party hereto and each of such party's respective present or
former subsidiaries, representatives, officers, directors, employees, agents, Affiliates, predecessors, successors and/or assigns from any and all claims, charges, controversies, covenants, rights,
promises, trespasses, damages, losses and expenses, debts, dues, demands, sums of money, actions, rights, causes of action, obligations and liabilities of any kind or nature whatsoever, at law or in
equity, whether asserted or unasserted, mature or contingent, know or unknown, accrued or unaccrued, which such releasing party may have had, claims to have had, now has, may claim to have or claims
to have, which are or may be based upon any facts, acts, conduct, representations, omissions, contracts, claims, events, causes, matters or things of any conceivable kind or character arising out of
or relating to the Original Agreement, arising on or prior to the date of this Agreement. Notwithstanding the foregoing, Buyer shall continue to be obligated to pay for Product delivered by Supplier
prior to the date of this Agreement in compliance with the terms of the Original Agreement. 

        9.     Entire Agreement. This Agreement (including Exhibits attached hereto) constitutes the entire agreement between the parties
relating to the supply of Product by NSC to Buyer. All prior agreements or arrangements between the parties relating to the supply of aspartame, whether written or oral, including the Original
Agreement and that certain agreement dated November 1, 2002 pursuant to which Buyer agreed to extend a right of first refusal to NSC for the supply of aspartame in 2005 but excluding any
trademark license agreements, are hereby canceled and superseded. This Agreement may not be modified except in writing signed by both parties. 

        10.   Definitions. The term "Affiliate" of a person or entity, as used herein or in the Exhibits hereto, shall mean as to such
person or entity, (a) any other person or entity directly, or indirectly through one or more intermediaries, controlling, controlled by, or under common control with such person or entity,
(b) any officer, director, partner, member, employee, or direct or indirect beneficial owner of 10% or 

3

 

more
of the equity or voting interests of such person or entity, or (c) any subsidiary of any such person or entity; and, in the case of NSC, the term
"Affiliate" shall include NutraSweet A.G., a Swiss corporation, and Euro-Aspartame, S.A., a French corporation. 

        11.   Successors and Assigns. This Agreement and the rights and obligations hereunder may not be assigned, provided that this
Agreement may be assigned to, and the rights and obligations hereunder shall be binding upon and inure to the benefit of, (i) either party's legal successors and assigns through a
reorganization, merger, business combination or similar transaction, or (ii) the acquiror of all or substantially all of the stock of either party or any material portion of the stock or assets
of the Buyer's Business or NSC's sweetener ingredients business. 

*
* * * * 

        IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the sate first written above. 

	THE NUTRASWEET COMPANY	 	MERISANT COMPANY
	

By:	
 	

/s/  CRAIG R. PETRAY      
	
 	

By:	
 	

/s/  ETIENNE J. VEBER      

	Name:	 	Craig R. Petray	 	Name:	 	Etienne J. Veber
	Title:	 	President	 	Title:	 	President, CEO
	

 	
 	

 	
 	
MERISANT COMPANY 1 SARL
	

 	
 	

 	
 	

By:	
 	

/s/  ETIENNE J. VEBER      

	 	 	 	 	Name:	 	Etienne J. Veber
	 	 	 	 	Title:	 	President, CEO

4

 
EXHIBIT A—Powder Product Specifications  

See
Attached. 

5

 
Quality Specifications  

	TITLE:	 	 	 	ASPARTAME, FCC—Raw
	

DOCUMENT NO.:	
 	

SUPERSEDES:	
 	

REVISION LEVEL:	
 	

CHANGE REFERENCE NO.:	
 	

EFFECTIVE DATE:
	
10039854	
 	

03/23/2000	
 	

A	
 	

875-00-3543	
 	

04/25/2002

       

	1.0	 	DESCRIPTION	 	 
	

 	
 	

1.1	
 	

Color:	
 	

White	
 	

 
	

 	
 	

1.2	
 	

Form:	
 	

Powder	
 	

 
	

 	
 	

1.3	
 	

Taste:	
 	

Sweet	
 	

 
	

 	
 	

1.4	
 	

Odor:	
 	

Characteristic, odorless	
 	

 
	

 	
 	

1.5	
 	

Clarity in Solution:	
 	

Clear	
 	

 
	

 	
 	

1.6	
 	
Molecular Formula	
 	

C14H18N2O5	
 	

 
	

 	
 	

 	
 	
Molecular Weight	
 	

294.3	
 	

 
	

 	
 	

 	
 	
Molecular Structure	
 	

 	
 	

 
	
A	
 	

1.7	
 	

STATUS	
 	

Kosher Certified	
 	

 
	
2.0	
 	
CHEMICAL TESTS	
 	

ACCEPTANCE CRITERIA	
 	

METHOD
	

 	
 	

2.1	
 	

Assay (dried basis)	
 	

98.0-102.0%	
 	

CM001
	

 	
 	

2.2	
 	

Diketopiperazine (DKP)	
 	

NMT 1.5%	
 	

CM001
	

 	
 	

2.3	
 	

Heavy Metals	
 	

Not More Than 10 ppm	
 	

CM004
	

 	
 	

2.4	
 	

Loss on Drying	
 	

Not More Than 4.0%	
 	

CM054
	

 	
 	

2.5	
 	

Transmittance	
 	

Not Less Than 95.0%	
 	

CM114
	

 	
 	

2.6	
 	

Residue on Ignition	
 	

Not More Than 0.20%	
 	

CM003
	
3.0	
 	
MICROBIOLOGICAL TESTS	
 	

ACCEPTANCE CRITERIA	
 	

METHOD
	

 	
 	

3.1	
 	

Total Aerobic Bacteria	
 	

Not More Than 250 cfu per gram	
 	

MM001
	

 	
 	

3.2	
 	
Escherichia Coli	
 	

None Detectable	
 	

MM005
	

 	
 	

3.3	
 	
Salmonella	
 	

None Detectable	
 	

MM005
	

 	
 	

3.4	
 	

Total Fungal Count	
 	

Not More Than 100 cfu per gram	
 	

MM001
	

 	
 	

3.5	
 	

Total Coliform Count	
 	

Not More Than 10 cfu per gram	
 	

MM001
	
4.0	
 	
PHYSICAL TESTS	
 	

ACCEPTANCE CRITERIA	
 	

METHOD
	

 	
 	

4.1	
 	

Color and Form	
 	

Conforms to Description	
 	

PM002
	

 	
 	

4.2	
 	

Odor	
 	

Conforms to Description	
 	

PM002
	

 	
 	

4.3	
 	

Taste	
 	

Conforms to Description	
 	

PM002
	

 	
 	

4.4	
 	

Particle Size	
 	

% retained on 100 mesh Not More Than ***%	
 	

PM031
	

 	
 	

4.5	
 	

Density	
 	

0.15—0.20 g/mL (Loose)	
 	

PM057
	

 	
 	

4.6	
 	

Specific Rotation (20°)	
 	

+14.5° to +16.5°	
 	

PM037
	

 	
 	

4.7	
 	

Color	
 	

LT 1.75 YI	
 	

PM079
	 	 	 	 	 	 	 	 	 

6

 

	
5.0	
 	
SAMPLING	
 	

 	
 	

 	
 	

 
	

 	
 	

Refer to SM101	
 	

 	
 	

 
	
6.0	
 	
STORAGE	
 	

 	
 	

 	
 	

 
	

 	
 	

6.1	
 	

Preserve in well-closed containers	
 	

 	
 	

 
	

 	
 	

6.2	
 	

Storage areas must meet food regulation sanitation conditions for dry food products.
	
7.0	
 	
VENDOR SHIPPING UNIT AND DOCUMENT MARKING
	

 	
 	

7.1	
 	

NCPI Specification (Component Part) Number.
	

 	
 	

7.2	
 	

NCPI Purchase order Number.
	

 	
 	

7.3	
 	

Vendor Name and Address.
	

 	
 	

7.4	
 	

Vendor Production Lot(s).
	

 	
 	

7.5	
 	

Manufacturer's Name and Manufacturing site (If different from vendor).
	

 	
 	

7.6	
 	

Quantity.	
 	

 	
 	

 
	

 	
 	

7.7	
 	

Description.	
 	

 	
 	

 

"Approval signatures on file electronically at Merisant Company Quality Assurance Headquarters"

Julie M. Williams/Merisant; James L. Pumphrey/Merisant

—oOo- 

7

   EXHIBIT B—FINE GRANULAR PRODUCT SPECIFICATIONS  

        See Attached. 

8

 

	 
	 	 
	 	 
	 	 
	 	 

	The NutraSweet Company	 	Sales Specification
	

TITLE:	
 	

 	
 	

 	
 	

 	
 	

 
	ASPARTAME, GRANULAR
	

	DOCUMENT

NUMBER:	 	REVISION

LEVEL:	 	MOC

NUMBER:	 	EFFECTIVE

DATE:	 	MATERIAL:
	
AE-SL-10-001	
 	

B	
 	

18-1645	
 	

01-June-2000	
 	

Granular
	

(L-Aspartyl L-Phenylalanine Methyl Ester)

	 
	 	 
	 	 
	 	 

	        DESCRIPTION	 	 
	

 	
 	
CAS	
 	

[22839-47-0]	
 	

 
	

 	
 	
MOLECULAR WEIGHT	
 	

294.3	
 	

 
	

 	
 	
FORM	
 	

Granular	
 	

 
	

 	
 	
MOLECULAR FORMULA	
 	

C14H18N2O5	
 	

 
	

 	
 	
COLOR	
 	

White	
 	

 
	

 	
 	
ODOR	
 	

Odorless	
 	

 
	

 	
 	
TASTE	
 	

Sweet	
 	

 
	

 	
 	
SOLUBILITY	
 	

Sparingly soluble in water; slightly soluble in alcohol	
 	

 

9

 

	 
	 	 
	 	 
	 	 

	 	 	TEST	 	ACCEPTANCE CRITERIA	 	REQUIRED BY
	

1.	
 	

IDENTITY	
 	

 	
 	

 
	

 	
 	

Identification Test (Infrared or HPLC)	
 	

Conforms to Standard	
 	

FCC, NF, EU
	
2.	
 	

STRENGTH	
 	

 	
 	

 
	

 	
 	

Assay (dried basis)	
 	

98.0% to 102.0%	
 	

FCC, NF, EU
	
3.	
 	

QUALITY	
 	

 	
 	

 
	

 	
 	

pH (0.8% solution)	
 	

Between 4.5 and 6.0	
 	

FCC, EU
	 	 	Specific Rotation @ 20°C	 	+14.5° to +16.5°	 	FCC, NF, EU
	
4.	
 	

PURITY	
 	

 	
 	

 
	

 	
 	

Arsenic (as As)	
 	

NMT 3 ppm	
 	

EU
	 	 	Diketopiperazine	 	NMT 1.5%	 	FCC, NF, EU
	 	 	Heavy Metals (as Pb)	 	NMT 10 ppm	 	FCC, NF, EU
	 	 	Loss on Drying	 	NMT 4.5%	 	FCC, NF, EU
	 	 	Residue on ignition	 	NMT 0.2%	 	FCC, NF, EU
	 	 	Lead	 	NMT 1 ppm	 	EU
	 	 	Transmittance	 	NLT 95.0%	 	NF, EU
	 	 	Other Related Substances	 	NMT 2.0%	 	FCC
	 	 	OR	 	 	 	 
	 	 	Chromatographic Impurities	 	 	 	NF
	 	 	Organic Volatile Impurities	 	Passes	 	NF
	
5.	
 	

MICROBIOLOGICAL PROFILE
	

 	
 	

Total Aerobic Bacteria	
 	

NMT 250 per 1.0 gram	
 	

NKC
	 	 	Fungi	 	NMT 100 per 1.0 gram	 	NKC
	 	 	Microorganisms of Public Health Concern	 	None	 	NKC
	
6.	
 	

PHYSICAL PROPERTIES
	

 	
 	

Particle size distribution
	 	 	    % Retained on 20 mesh	 	NMT 3.0%	 	NKC
	 	 	    % Retained on 60 mesh	 	80—100%	 	NKC
	 	 	    % Through 80 mesh	 	NMT 3.5%	 	NKC
	 	 	Unpacked Density	 	0.60+/-0.10 g/MI	 	NKC
	
7.	
 	

PACKAGING	
 	

 	
 	

 
	

 	
 	

Refer to Bill of Material for specific packaging requirements.
	
8.	
 	

STORAGE	
 	

 	
 	

 
	

 	
 	

Avoid high heat and store under dry conditions.
	
9.	
 	

STABILITY/RE-EVALUATION
	 	 	Five years at ambient room temperature storage conditions (typically 15°C to 30°C; 35% to 60% relative humidity). Product should be re-evaluated after this period.

	

 	
 	

APPROVED BY:	
 	

	
 	

DATE:	
 	

	 	 	 	 	QA PROJECT LEADER	 	 	 	 

10

 
EXHIBIT C—OTHER TERMS AND CONDITIONS  

OTHER TERMS AND CONDITIONS  

	1.
	TERMS. The sale of the product or services described in the contract or invoice of which these terms and conditions are a part (or are
on the face hereof) ("PRODUCT") by The NutraSweet Company or its Affiliates ("SELLER") to the buyer identified in the attached contract or invoice ("BUYER") is governed by the following terms and
conditions. Seller expressly rejects any additional or different terms or conditions proposed by Buyer.

	2.
	FORCE MAJEURE. Either party's failure to perform its obligations hereunder (except to make payments hereunder) shall be excused to the
extent and for the period of time such nonperformance is caused by an event of force majeure, including but not limited to war, invasion, fire, explosion, food, riot, strikes, acts of God, delays or
defaults of carriers, energy shortage, inability to obtain raw materials, acts of government, its agencies or instrumentalities, or contingencies or causes beyond such party's reasonable control.

	3.
	PRICE, All prices are *** nearest *** in ***, *** and *** and *** in ***. For avoidance of doubt, *** shall pay ***. Seller will use
commercially reasonable efforts to have shipments made in accordance with any timely instructions of Buyer or estimated dates provided in writing to Seller. Title to, and risk of loss of, any shipment
hereunder will *** at ***.

	4.
	PAYMENT AND TERMINATION. Unless otherwise stated in writing by the Seller, the price for the Product is payable *** and payment is due
to Seller within *** of the date of invoice. Any amounts not paid when due will have interest from the date due until paid at an annual rate equal to ***% *** in effect at *** on the date such payment
was due. Seller reserves the right, among other remedies, either to *** or to *** under it in the event Buyer *** for *** after notice of such *** and failure to cure within *** of receipt of such
notice. Should *** become unsatisfactory to ***, *** or *** satisfactory to *** may be required by *** for *** and for ***.

	5.
	WARRANTIES BY SELLER. Seller hereby warrants to Buyer with respect to the Product that:

	(a)
	It
has good and marketable title to the Product shipped to Buyer hereunder;

	(b)
	At
the time of shipment to Buyer, the Product will meet Seller's then current specifications; and

	(c)
	For
Product sold as a food ingredients product, at the time of shipment to Buyer, the Product will not be adulterated or misbranded within the meaning of the United States Food, Drug
and Cosmetic Act or any of the regulations thereunder. 

THE
WARRANTIES SET FORTH IN THIS SECTION 5 ARE IN LIEU OF ANY AND ALL OTHER WARRANTIES, REPRESENTATIONS OR CONDITIONS, EXPRESS OR IMPLIED,
COLLATERAL, STATUTORY OR OTHERWISE, AND WHETHER IN CONTRACT, TORT OR OTHERWISE SALE OF THE PRODUCT IS MADE ON THE UNDERSTANDING THAT THERE ARE NO EXPRESS OR IMPLIED WARRANTIES THAT THE PRODUCT
DELIVERED HEREUNDER WILL BE MERCHANTABLE OR FIT FOR ANY PARTICULAR PURPOSE. 

	6.
	LIMITATION ON CLAIMS. All claims that any shipments hereunder does not conform to the above warranties will be waived by Buyer with
respect to such shipment unless written notice is given to Seller by Buyer accompanied by a sample of the alleged non-conforming Product within *** after Buyer's receipt of the shipment.
Buyer shall not conduct any post sales audit of compliance with any terms and condition of sale and hereby waives any claims resulting therefrom unless such audit and claim are completed within two
years of the date of the relevant order. 

11

 
	7.
	REPLACEMENT OR CREDIT BY SELLER. Seller will notify Buyer within 30 days after receipt of Buyer's notice provided pursuant to
Section 6 above whether Seller accepts Buyer's claims. If Seller accepts such claim, it will instruct Buyer either to return the shipment or destroy it, and Buyer will promptly comply with such
instruction at Seller's expense. Seller will promptly replace any such Product at its own expense on the same shipping terms as the original shipment or issue a credit note to Buyer for such shipment
including shipping charges paid by Buyer.

	8.
	LIMITED REMEDY. Except as provided in Article 10A with respect to third party claims, the exclusive remedy of Buyer arising out
of breach of the above warranties will be replacement or credit, at Seller's option.

	9.
	LIMITATION OF LIABILITY. Seller will not in any event be liable to Buyer, to Buyer's Affiliates, or to Buyer's franchisees,
co-packers, or distributors (if any) for special, indirect or consequential damages (including but not limited to lost profits, manufacturing costs, damage to goodwill, or loss of
business), or product recall costs whether based on the use of Product or any goods, incorporating Product (whether or not the Product involved conforms to Seller's specifications and warranties set
forth herein) or on Seller's late delivery or non-delivery of Product.

	10.
	INDEMNITY.

	(a)
	IN FAVOR OF BUYER. Seller will indemnify, defend and hold harmless Buyer, its Affiliates and their respective officers, directors,
employees, agents and representatives from and against liability, damage, loss, cost or expense (including reasonable attorney's fees and costs) arising out of any third party claims or suits
resulting from Seller's negligent act or omission, breach of this Agreement or breach of warranty in the manufacture or sale of Product hereunder.

	(b)
	IN FAVOR OF SELLER. Buyer will indemnify, defend and hold harmless Seller, its Affiliates and their respective officers, directors,
employees, agents and representatives from and against any and all liability, damage, loss, cost or expense (including reasonable attorney's fees and costs) of any kind or nature whatsoever arising
out of any third party claims or suits resulting from (a) Buyer's negligent act or omission in connection with the purchases, storage, use, sale, shipment, promotion, or distribution of Product
sold hereunder or of any goods (including their manufacture and sale) in which Product is incorporated; (b) product liability claims relating to the manufacture, promotion or sale of Buyer's
goods incorporating Products; and (c) claims of contributory infringement or inducement of infringement against Seller based on infringement by Buyer of any third party intellectual property
right(s) covering Buyer's goods incorporating Product, including all materials or intermediates produced or used in their manufacture (excluding Product) or method(s) for its manufacture or use.

	(c)
	NOTICE OF CLAIM. Promptly after receiving notice of any claim or lawsuit to which this Section 10 applies, the party seeking to
be indemnified will notify the other party in writing, and the party so notified will immediately assume responsibility at its sole expense for the handling and defense of such claim or suit on behalf
of the party entitled to indemnify. The parties will fully cooperate with each other on such defense.

	11.
	TAXES. Buyer will pay all sales, revenue, excise or other federal, state, local or foreign taxes (including value added and consumption
taxes) and all import or export duties payable with respect to any shipment hereunder, excluding Ad Valorem taxes of Seller and taxes based on Seller's net income.

	12.
	GOVERNING LAW. The contract or invoice of which these terms and conditions are a part (or are on the face hereof) shall be governed by,
and interpreted in accordance with the laws of the State of Illinois, U.S. except any such law mandating the application of the law(s) of a different jurisdiction. 

12

 
	13.
	LAW VIOLATION. If any provision hereof is or becomes, a violation of any law, rule, order or regulation issued thereunder, Seller shall
have the right, upon notice to Buyer, to cancel such provision without effect upon the other provisions, or to cancel further deliveries in their entirety.

	14.
	INTELLECTUAL PROPERTY.

	(a)
	PATENTS. Seller warrants that, to its knowledge, the sale of the material hereunder will not infringe the claims of any United States
Patent covering the material itself, but in the event that it is alleged that such sale constitutes infringement of such patent, then Seller's liability to Buyer shall:

	(i)
	be
limited to the defense of such infringement actions and the payment of damages awarded therefor by a court of competent jurisdiction from which no appeal is or can be taken, or the
settlement of such actions, as Seller shall elect, and

	(ii)
	arise
only if Buyer promptly gives Seller written notice of such claim and full authority, information and assistance for the defense and/or settlement of such claim. 

	

	This
section 14(a) states the entire liability of Seller with respect to patent infringements by said materials. Seller does not warrant against
infringement by reason of any use of the material or of its combination with any other material or in the operation of any process. Seller reserves the right to suspend deliveries hereunder, or to
terminate this contract, if Seller believes that the manufacture and/or sale by Seller, or the use by Buyer, of any material sold hereunder infringes any Patent.

	(b)
	TRADEMARK USAGE. Buyer agrees that, if Seller grants Buyer any right to use any Seller trademark, unless as otherwise provided in any
separate agreement between Buyer and Seller, its use of the Seller trademarks and the advertising and packaging of Buyer's goods will be in accordance with Seller's policies and procedures with
respect to the use of any of Seller's trademarks as provided to Buyer from time to time. Buyer will not grant rights of any kind of the Seller trademarks to any third party. 

	15.
	NO RIGHT OF SET-OFF. Buyer waives any right it now has or later acquires to set off any amount due from Seller or its
affiliates against amounts owed by Buyer hereunder.

	16.
	ALLOCATION. If Seller determines that its ability to supply the total demand for the product, or obtain any or a sufficient quantity of
any material used directly, or indirectly in the manufacture of the Product, is hindered, limited or made impracticable, Seller may allocate its available supply of the Product or such material
(without obligation to acquire other supplies or any such product or material) among itself and its customers on such basis as Seller determines to be equitable and without liability for any failure
of performance which may result therefrom.

	17.
	ASSIGNMENT. The terms, conditions and obligations of this Agreement will inure to the benefit of and be binding upon the parties hereto
and the respective successors and assigns thereof. This Agreement and the rights and obligations hereunder may not be assigned, provided that this Agreement may be assigned to, and the rights and
obligations hereunder shall be binding upon and inure to the benefit of, (i) either party's legal successors and assigns through a reorganization, merger, business combination or similar
transaction, or (ii) the acquiror of all or substantially all of the stock of either party or any material portion of the stock or assets of the Buyer's Business or NSC's sweetener ingredients
business.

	18.
	SEVERABILITY. The provisions contained herein are severable and the contract or invoice of which these terms and conditions are a part
(or are on the face hereof() shall be interpreted as if all completely invalid or unenforceable provisions were not contained herein and partially valid and enforceable provisions shall be enforced to
the extent valid and enforceable. If any applicable and binding law or rule of any jurisdiction renders any provision of the contract or invoice of which these terms and conditions are a part (or are
on the face hereof) unenforceable, the parties 

13

 

hereto
agree to modify, or any modification made or ordered by any court, arbitrator, or governmental agency of, such invalid or unenforceable provision, to the extent required to be valid and
enforceable in such jurisdiction. Such modifications to this Agreement shall be effective only in such jurisdiction and the contract or invoice of which these terms and conditions are a part (or are
on the face hereof) shall be enforced as originally made and entered into in all other jurisdictions. 

14

 
EXHIBIT D—PRICING  

	 
	 	 
	 	 

	1.	 	During calendar year 2004, volume, price and Territory for Product will be as follow:
	

 	
 	

Volume:	
 	

*** of Powder Product
	

 	
 	

Price:	
 	

$*** per *** for Powder Product
	

 	
 	

Territory:	
 	

***
	

2.	
 	

During calendar year 2005, volume, price and Territory for the Product will be as follows:
	

 	
 	

Volume:	
 	

*** of Product
	

 	
 	

Price	
 	

$*** per *** for Powder Product
	

 	
 	

 	
 	

$*** per *** for Fine Granular Product
	

 	
 	

Territory:	
 	

***

CONFIDENTIAL MATERIAL APPEARING IN THIS DOCUMENT WAS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION IN ACCORDANCE WITH RULE 24b-2,
PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. OMITTED INFORMATION WAS REPLACED WITH ASTERISKS.

15

QuickLinks

Exhibit 10.8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]